| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 58,809 | 57,870 | 55,700 | 54,692 | | Cost of Revenue | 28,665 | 28,852 | 29,121 | 29,300 | | | Gross Profit | 30,144 | 29,018 | 26,579 | 25,392 | | | Operating Expenses | | Research Development | 3,391 | 3,514 | 4,132 | 2,557 | | Selling General and Administrative | 25,471 | 25,280 | 32,318 | 25,869 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,282 | 224 | (9,871) | (3,034) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 195 | 1,273 | 915 | 678 | | Earnings Before Interest And Taxes | 1,477 | 1,497 | (8,956) | (2,356) | | Interest Expense | 27 | 76 | 50 | 71 | | Income Before Tax | 1,450 | 1,421 | (9,006) | (2,427) | | Income Tax Expense | 1,665 | (766) | (3,381) | (1,362) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (215) | 2,187 | (5,625) | (1,065) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (215) | 2,187 | (5,625) | (1,065) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($215) | $2,187 | ($5,625) | ($1,065) |
|
0.32% Nasdaq 
0.15%
Income Statement
